Apolipoprotein-E-deficient mice exhibit an increased susceptibility to disseminated candidiasis

References

• Rex JH, Bennett JE, Sugar AM, Pappas PG, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994; 331: 1325–1330.
   PubMed Web of Science ®Google Scholar
• Fraser VJ, Jones M, Dunkel J, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992; 15: 414–421.
   Google Scholar
• D'Angio R, Quercia RA, Treiber NK, McLaughlin JC, Klimek JJ. The growth of microorganisms in total parenteral nutrition admixtures. J Parenter Enteral Nutr 1987; 11: 394–397.
   PubMed Web of Science ®Google Scholar
• Mershon J, Nogami W, Williams JM, Yoder C, Eitzen HE, Lemons JA. Bacterial/fungal growth in a combined parenteral nutrition solution. J Parenter Enteral Nutr 1986; 10: 498–502.
   Google Scholar
• Netea MG, Demacker PN, De Bont N, et al. Hyperlipoproteine-mia enhances susceptibility to acute disseminated Candida albicans infection in low-density- lipoprotein-receptor-deficient mice. Infect Immun 1997; 65: 2663–2667.
   PubMed Web of Science ®Google Scholar
• Netea MG, Curfs JH, Demacker PN, Meis JF, van der Meer JW, Kullberg BJ. Infusion of lipoproteins into volunteers enhances the growth of Candida albicans. Clin Infect Dis 1999; 28: 1148–1151.
   Google Scholar
• Mistry MJ, Clay MA, Kelly ME, Steiner MA, Harmony JA. Apolipoprotein E restricts interleukin-dependent T lymphocyte proliferation at the G1A/G1B boundary. Cell Immunol 1995; 160: 14–23.
   Google Scholar
• Kelly ME, Clay MA, Mistry MJ, Hsieh Li HM, Harmony JA. Apolipoprotein E inhibition of proliferation of mitogen- activated T lymphocytes: production of interleukin 2 with reduced biolo-gical activity. Cell Immunol 1994; 159: 124–139.
   Google Scholar
• Terkeltaub RA, Dyer C A, Martin J, Curtiss LK. Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intra-articular apo E and demonstration of apo E binding to urate crystals in vivo. J Clin Invest 1991; 87: 20–26.
   Google Scholar
• Pepe MG, Curtiss LK. Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In. J Immunol 1986; 136: 3716–3723.
   PubMed Web of Science ®Google Scholar
• Roselaar SE, Daugherty A. Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. J Lipid Res 1998; 39: 1740–1743.
   Web of Science ®Google Scholar
• de Bont N, Netea MG, Demacker PN, et al. Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res 1999; 40: 680–685.
   PubMed Web of Science ®Google Scholar
• de Bont N, Netea MG, Demacker PN, Kullberg BJ, van der Meer JW, Stalenhoef AF. Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae. Eur J Can Invest 2000; 30: 818–822.
   Google Scholar
• Van Oosten M, Rensen PC, Van Amersfoort ES, et al. Apolipo-protein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis. J Biol Chem 2001; 276: 8820–8824.
   Google Scholar
• van Ree JH, van den Broek WJ, Dahlmans VE, et al. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. Atherosclerosis 1994; 111: 25–37.
   Google Scholar
• Kullberg BJ, van't Wout JW, van Furth R. Role of granulocytes in increased host resistance to Candida albicans induced by recom-binant interleukin-1. Infect Immun 1990; 58: 3319–3324.
   Google Scholar
• Vogels MT, Mensink EJ, Ye K, et al. Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1-induced resistance to infection. J Immunol 1994; 153: 5772–5780.
   Google Scholar
• Vonk AG, Wieland CW, Netea MG, Kullberg BJ. Phagocytosis and intracellular killing of Candida albicans blastoconidia by neutrophils and macrophages: a comparison of different micro-biological test systems. J Microbiol Methods 2002; 49: 55–62.
   PubMed Web of Science ®Google Scholar
• Gaviria JM, van Bunk JA, Dale DC, Root RK, Liles WC. Modulation of neutrophil-mediated activity against the pseudo-hyphal form of Candida albicans by granulocyte colony- stimulat-ing factor (G-CSF) administered in vivo. J Infect Dis 1999; 179: 1301–1304.
   PubMed Web of Science ®Google Scholar
• Lundqvist H, Dahlgren C. Isoluminol-enhanced chemilumines-cence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radic Biol Med 1996; 20: 785–792.
   PubMed Web of Science ®Google Scholar
• Demacker PN, van Sommeren-Zondag DF, Stalenhoef AF, Stuyt PM, van't Laar A. Ultracentrifugation in swinging-bucket and fixed-angle rotors evaluated for isolation and determination of high-density lipoprotein subfractions HDL2 and HDL3. Clin Chem 1983; 29: 656–663.
   Google Scholar
• Murthy AR, Lehrer RI, Harwig SS, Miyasaki KT. In vitro candidastatic properties of the human neutrophil calprotectin complex. J Immunol 1993; 151: 6291–6301.
   PubMed Web of Science ®Google Scholar
• Payne CD, Ray TL, Downing DT. Cholesterol sulfate protects Candida albicans from inhibition by sphingosine in vitro. J Invest Dermatol 1996; 106: 549–552.
   Google Scholar
• Yeaman MR, Ibrahim AS, Edwards Jr. JE, Bayer AS, Ghannoum MA. Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro. Ant imicrob Agents Chemother 1993; 37: 546–553.
   Google Scholar
• Casadevall A. Antibody immunity and invasive fungal infections. Infect Immun 1995; 63: 4211–4218.
   PubMed Web of Science ®Google Scholar
• Hasenclever HF. The in vitro interactions of Candida albicans with nonspecific serum proteins. Mycopathologia 1978; 65: 169–176.
   PubMedGoogle Scholar
• Leunk RD, Moon RI. Physiological and metabolic alterations accompanying systemic candidiasis in mice. Infect Immun 1979; 26: 1035–1041.
   Google Scholar
• Wanten GJ, Curfs JH, Meis JF, Naber AH. Phagocytosis and killing of Candida albicans by human neutrophils after exposure to structurally different lipid emulsions. J Parenter Enteral Nutr 2001; 25: 9–13.
   Google Scholar
• Laskowitz DT, Lee DM, Schmechel D, Staats HF. Altered immune responses in apolipoprotein E-deficient mice. J Lipid Res 2000; 41: 613–620.
   PubMed Web of Science ®Google Scholar